Cartesian Therapeutics, Inc. RNAC
- Descartes-08 — Myasthenia Gravis Phase 3
- Descartes-08 — Dermatomyositis Phase 1
- Descartes-08 — Antisynthetase Syndrome Phase 2
- Descartes-15 — Multiple Myeloma Phase 1
BCMA (9 companies · 16 programs)
Companies with an active program directed at BCMA.
Cullinan Therapeutics, Inc. CGEM
- velinotamig — Systemic Lupus Erythematosus Phase 1
- velinotamig — Immune Thrombocytopenia Preclinical
- velinotamig — Autoimmune Hemolytic Anemia Preclinical
Autolus Therapeutics plc AUTL
- AUTO8 — Relapsed/Refractory Multiple Myeloma Phase 1
- AUTO8 — Light Chain Amyloidosis Phase 1
Legend Biotech Corp LEGN
- CARVYKTI — Relapsed/Refractory Multiple Myeloma Approved
- LB2405 Phase 1
Allogene Therapeutics, Inc. ALLO
- ALLO-715 — Multiple Myeloma Phase 1
Caribou Biosciences, Inc. CRBU
- CB-011 — Relapsed/Refractory Multiple Myeloma Phase 1
Immix Biopharma, Inc. IMMX
- NXC-201 — Relapsed/Refractory AL Amyloidosis Phase 1
MiNK Therapeutics, Inc. INKT
- MiNK-413 Preclinical
Sana Biotechnology, Inc. SANA
- SG227 — Multiple Myeloma Preclinical